Krum H - Search Results

1

Sympathetic Response and Outcomes Following Renal Denervation in Patients With Chronic Heart Failure: 12-Month Outcomes From the Symplicity HF Feasibility Study.

Hopper I, Gronda E, Hoppe UC, Rundqvist B, Marwick TH, Shetty S, Hayward C, Lambert T, Hering D, Esler M, Schlaich M, Walton A, Airoldi F, Brandt MC, Cohen SA, Reiters P, Krum H. Hopper I, et al. Among authors: krum h. J Card Fail. 2017 Sep;23(9):702-707. doi: 10.1016/j.cardfail.2017.06.004. Epub 2017 Jun 20. J Card Fail. 2017. PMID: 28645757 Clinical Trial.

2

Beta-adrenoceptor blockers in chronic heart failure--a review.

Krum H. Krum H. Br J Clin Pharmacol. 1997 Aug;44(2):111-8. doi: 10.1046/j.1365-2125.1997.00659.x. Br J Clin Pharmacol. 1997. PMID: 9278193 Free PMC article. Review.

3

Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy. Australia/New Zealand Heart Failure Research Collaborative Group.

Krum H, Shusterman N, MacMahon S, Sharpe N. Krum H, et al. J Card Fail. 1998 Dec;4(4):281-8. doi: 10.1016/s1071-9164(98)90233-0. J Card Fail. 1998. PMID: 9924849 Clinical Trial.

4

Baseline predictors of tolerability to carvedilol in patients with chronic heart failure.

Krum H, Ninio D, MacDonald P. Krum H, et al. Heart. 2000 Dec;84(6):615-9. doi: 10.1136/heart.84.6.615. Heart. 2000. PMID: 11083738 Free PMC article.

5

Comparative effects of mibefradil and nifedipine gastrointestinal transport system on autonomic function in patients with mild to moderate essential hypertension.

Pellizzer AM, Kamen PW, Esler MD, Lim S, Krum H. Pellizzer AM, et al. Among authors: krum h. J Hypertens. 2001 Feb;19(2):279-85. doi: 10.1097/00004872-200102000-00015. J Hypertens. 2001. PMID: 11212971 Clinical Trial.

6

Diagnostic and therapeutic potential of the endothelin system in patients with chronic heart failure.

Krum H, Denver R, Tzanidis A, Martin P. Krum H, et al. Heart Fail Rev. 2001 Dec;6(4):341-52. doi: 10.1023/a:1011416611765. Heart Fail Rev. 2001. PMID: 11447309 Review.

7

Improved outcomes from a comprehensive management system for heart failure.

Holst DP, Kaye D, Richardson M, Krum H, Prior D, Aggarwal A, Wolfe R, Bergin P. Holst DP, et al. Among authors: krum h. Eur J Heart Fail. 2001 Oct;3(5):619-25. doi: 10.1016/s1388-9842(01)00164-7. Eur J Heart Fail. 2001. PMID: 11595611 Free article.

8

Tumor necrosis factor-alpha blockade as a therapeutic strategy in heart failure (RENEWAL and ATTACH): unsuccessful, to be specific.

Krum H. Krum H. J Card Fail. 2002 Dec;8(6):365-8. doi: 10.1054/jcaf.2002.130237. J Card Fail. 2002. PMID: 12528087 Review. No abstract available.

9

Should patients with chronic heart failure be treated with "statins"?

Ashton E, Liew D, Krum H. Ashton E, et al. Among authors: krum h. Heart Fail Monit. 2003;3(3):82-6. Heart Fail Monit. 2003. PMID: 12634877 Review.

10

Why do phase III trials of promising heart failure drugs often fail? The contribution of "regression to the truth".

Krum H, Tonkin A. Krum H, et al. J Card Fail. 2003 Oct;9(5):364-7. doi: 10.1054/s1071-9164(03)00018-6. J Card Fail. 2003. PMID: 14583896 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

591 results

Search Page

Filters